MAIA Biotechnology, Inc. (MAIA) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
分析师预估 每股收益(EPS)为 $-1.49 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.05 vs 预期 $-1.49 (超预期 +29.3%). 2025: 实际 $-0.70 vs 预期 $-0.74 (超预期 +5.4%). 分析师准确度: 76%.
